In a comparison of citywide COVID-19 hospitalization rates prior to and during the program, COVID-19 mortality decreased from 6.8% before the program with prophylactic use of ivermectin, to 1.8% after its beginning (RR, 0.27; 95% CI, 0.21-0.33; p < 0.0001), and in COVID-19 mortality rate, from 3.4% to 1.4% (RR, 0.41; 95% CI, 0.31-0.55; p < 0.0001)
https://www.cureus.com/articles/82162-i ... e-matching
...